Callos Andrew: insider trades.
Callos Andrew reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($3.1M), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Callos Andrew
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Cytokinetics Inc (CYTK) | Officer · EVP, Chief Commercial Officer | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-31 | Cytokinetics Inc | M | 10,000 | $23.26 | 68,555 | Form 4 |
| 2026-08-31 | Cytokinetics Inc | S | 10,000 | $70.24 | 58,555 | Form 4 |
| 2026-07-30 | Cytokinetics Inc | M | 14,000 | $23.26 | 72,555 | Form 4 |
| 2026-07-30 | Cytokinetics Inc | S | 14,000 | $79.88 | 58,555 | Form 4 |
| 2026-07-01 | Cytokinetics Inc | S | 15,000 | $85.8 | 58,555 | Form 4 |
| 2026-07-01 | Cytokinetics Inc | M | 15,000 | $23.26 | 73,555 | Form 4 |
Questions
What stock did Callos Andrew buy or sell?
Callos Andrew reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($3.1M), across 1 company.
Is Callos Andrew the same person as other filers with this name?
This page covers SEC CIK 1852129 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/callos-andrew-1852129.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.